Epizyme reported $-64140000 in EBIT for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbott ABT:US $ 2522M 1123M
Agios Pharmaceuticals AGIO:US $ -91152000 70K
Amarin AMRN:US 1.04M 7.73M
Amgen AMGN:US $ 2378M 45M
Avrobio Inc AVRO:US $ -32620000 1.24M
Biogen BIIB:US $ 858.6M 171.5M
Bluebird Bio BLUE:US $ -196779000 44.06M
Cerulean Pharma CERU:US $ -12668940 3.51M
Daiichi Sankyo 4568:JP 38.97B 6.8B
Eisai 4523:JP 5.5B 49.91B
Epizyme EPZM:US $ -64140000 5.91M
Exelixis EXEL:US $ 51.62M 71.39M
Gilead Sciences GILD:US $ 3883M 1637M
GlaxoSmithKline GSK:LN 2.67B 712M
Glaxosmithkline GSK:US 2.67B 712M
Karyopharm Therapeutics KPTI:US $ -43812000 5.24M
Macrogenics MGNX:US $ -52987000 12.71M
Merk MRK:US $ 5352M 3083M
Mirati Therapeutics MRTX:US $ -79499000 84.69M
Novartis NOVN:VX 3.48B 77M
Novartis NVS:US 3.48B 77M
Pfizer PFE:US $ 9254M 2592M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M
Seattle Genetics SGEN:US $ -297963000 208.36M
Spectrum Pharmaceuticals SPPI:US $ -33093000 10.98M
Vertex Pharmaceuticals VRTX:US $ 1055.71M 1092.07M
Xencor XNCR:US $ -41300000 50.39M